Bio-Path Holdings, Inc.
Cash Flow Statement
| Line Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-9.9M | $-16.1M | $-13.9M | $-10.4M | $-10.9M | $-8.6M | $-8.6M | $-7.0M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $53.0K | $82.0K | $88.0K | $76.0K | $72.0K | $134.0K | $265.0K | $251.0K |
| Amortization | — | — | — | — | — | $0 | $161.0K | — |
| Stock-Based Compensation | $566.0K | $734.0K | $851.0K | $821.0K | $577.0K | $684.0K | $554.0K | $793.0K |
| Net Cash from Operating Activities | $-10.6M | $-11.5M | $-15.1M | $-9.9M | $-11.0M | $-8.4M | $-6.1M | $-8.0M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $21.0K | $70.0K | — | $0 | $17.0K | $538.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | $-21.0K | $-70.0K | — | $0 | $-17.0K | $-538.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $10.7M | $2.2M | $1.7M | $20.0M | $4.3M | $27.8M | $1.2M | $5.1M |
| Net Change in Cash | $121.0K | $-9.3M | $-13.4M | $10.0M | $-6.7M | $19.4M | $-5.0M | — |
| Free Cash Flow | — | — | $-15.1M | $-10.0M | — | $-8.4M | $-6.1M | $-8.5M |